Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
1.
J Adv Res ; 2024 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-38341032

RESUMEN

INTRODUCTION: One of the hallmarks of Parkinsons Disease (PD) is oxidative distress, leading to mitochondrial dysfunction and neurodegeneration. Insulin-like growth factor II (IGF-II) has been proven to have antioxidant and neuroprotective effects in some neurodegenerative diseases, including PD. Consequently, there isgrowing interest in understanding the different mechanisms involved in the neuroprotective effect of this hormone. OBJECTIVES: To clarify the mechanism of action of IGF-II involved in the protective effect of this hormone. METHODS: The present study was carried out on a cellular model PD based on the incubation of dopaminergic cells (SN4741) in a culture with the toxic 1-methyl-4-phenylpyridinium (MPP+), in the presence of IGF-II. This model undertakes proteomic analyses in order to understand which molecular cell pathways might be involved in the neuroprotective effect of IGF-II. The most important proteins found in the proteomic study were tested by Western blot, colorimetric enzymatic activity assay and immunocytochemistry. Along with the proteomic study, mitochondrial morphology and function were also studied by transmission electron microscopy and oxygen consumption rate. The cell cycle was also analysed using 7AAd/BrdU staining, and flow cytometry. RESULTS: The results obtained indicate that MPP+, MPP++IGF-II treatment and IGF-II, when compared to control, modified the expression of 197, 246 proteins and 207 respectively. Some of these proteins were found to be involved in mitochondrial structure and function, and cell cycle regulation. Including IGF-II in the incubation medium prevents the cell damage induced by MPP+, recovering mitochondrial function and cell cycle dysregulation, and thereby decreasing apoptosis. CONCLUSION: IGF-II improves mitochondrial dynamics by promoting the association of Mitofilin with mitochondria, regaining function and redox homeostasis. It also rebalances the cell cycle, reducing the amount of apoptosis and cell death by the regulation of transcription factors, such as Checkpoint kinase 1.

2.
Sci Data ; 11(1): 79, 2024 Jan 16.
Artículo en Inglés | MEDLINE | ID: mdl-38228642

RESUMEN

The big data revolution has made it possible to collect, transmit and exploit huge amounts of data. The potential this offer for data analysis, however, clashes with the limitations imposed by laws on protection of personal data. This paper details a new database (DEMOSPA0521) made after processing and summarising more than 868 million demographic records from Spain, corresponding to a period of seventeen years (2005-2021). DEMOSPA0521 is composed of fifteen files: a group of (monthly and daily moving averages) datasets derived from population stocks and a collection of (daily, monthly and quarterly) datasets obtained from population, death, migration and birth statistics. The intra-annual distributions were calculated by exploiting both the temporal dimensions of age and calendar. DEMOSPA0521 also includes eleven R-Code files that enables the summary datasets to be derived from the raw microdata. DEMOSPA0521 can be used to confirm established results and employed to answer new research questions.

3.
Data Brief ; 45: 108655, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36426067

RESUMEN

The foundation of the insurance business is built on data, the latter being one of the most valuable assets of any insurer. In fact, the risk structure to which an insurance company is exposed can actually be deduced by reviewing its customer database. It is not surprising, therefore, that access to real insurance datasets is very limited. This paper introduces and describes a dataset corresponding to a cross-section extraction of a real life-risk insurance portfolio. The dataset contains information on 76,102 policies and a total of 15 variables, including the capital at risk, the genders and dates of birth of the insured, and the effective and renewal dates of their policies. This dataset can be used both in teaching and in research. Combined with external life tables, the data available in the dataset can be used to build and compare pricing systems, to evaluate marketing strategies, in portfolio analysis, for calculations required by Solvency II regulations or for market benchmarking analysis. For example, the data from this dataset have been used in Pavía and Lledó [1] to compare the classic pricing methodology based on annual life tables with a new pricing methodology based on life tables with less than annual periodicity Pavía and Lledó [2], specifically quarterly, and in Lledó et al. to demonstrate the impact that using a new methodology to manage catastrophic risks in life insurance would have in terms of solvency capital requirements.

4.
Data Brief ; 40: 107763, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34977305

RESUMEN

2020 was a year marked by COVID-19, an infectious disease caused by the SARS-CoV-2 virus. Since the official beginning of the pandemic (March 2020), the authorities in Spain have been imposing significant restrictions (mainly on mobility) to stop the spread of the disease. In October 2020, the research group GIPEyOP (Elections and Public Opinion Research Group from the University of Valencia) conducted a survey to analyse whether the Spanish population has maintained or modified their habits and customs once the strict measures imposed in Spain during the onset of the pandemic were relaxed. This article describes the dataset collected, which is provided as an attachment. The dataset is made up of 196 variables, following elimination of those variables that could potentially identify the respondents to ensure their anonymity. Over 22 days, from September 23 to October 14, 2020, GIPEyOP collected 1755 valid responses. Respondents were contacted by chain or snowball sampling via email and social media and answered a self-administered web questionnaire consisting of 40 questions. amongst other uses, the resulting dataset can be (re)used to analyse whether the period of home confinement that Spaniards experienced between March and June 2020 has caused them to change their habits and customs, such as how often they do sport or go to bars or restaurants. The data also permit the study of whether there have been changes in the distribution of household chores by comparing three clearly differentiated moments (before confinement, during confinement and after confinement), what type of work (telework or face-to-face) the respondents would prefer or to know how the management of the crisis by govern authorities impacted on their votes preferences.

5.
Data Brief ; 40: 107700, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34909456

RESUMEN

This article introduces a dataset that captures relevant information about the living conditions, feelings, and habits of residents in Spain during ninety nine days of home confinement. This and other measures, imposed by the Government of Spain to mitigate the impact of the pandemic on the population, have brought with them important economic, labor, and social changes, which have been accompanied by various modifications (some only temporary) in Spaniards habits and behaviours. Data collection was carried out through the implementation of a questionnaire with 33 questions, which was sent by email to the collaborators of GIPEyOP (Elections and Public Opinion Research Group from the University of Valencia). These collaborators, in turn, forwarded the questionnaire to their acquaintances using email and social networks, mainly WhatsApp, Facebook, and Twitter. This non-probabilistic methodology has generated a total of 8387 valid responses. The resulting dataset may be (re)used by sociologists, political scientists, economists, or psychologists, among others, to identify how household chores were distributed among family members during the lockdown, what impact the confinement had on the labor performance of workers, the extent of teleworking and on some (physical and psychological) health issues linked to the confinement, including relationships with the place of residence during confinement. The data also provides information on how social networks spread geographically or what Spaniards thought of the management of the crisis by local, national, and international authorities.

6.
Redox Biol ; 46: 102095, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34418603

RESUMEN

Oxidative distress and mitochondrial dysfunction, are key factors involved in the pathophysiology of Parkinson's disease (PD). The pleiotropic hormone insulin-like growth factor II (IGF-II) has shown neuroprotective and antioxidant effects in some neurodegenerative diseases. In this work, we demonstrate the protective effect of IGF-II against the damage induced by 1-methyl-4-phenylpyridinium (MPP+) in neuronal dopaminergic cell cultures and a mouse model of progressive PD. In the neuronal model, IGF-II counteracts the oxidative distress produced by MPP + protecting dopaminergic neurons. Improved mitochondrial function, increased nuclear factor (erythroid-derived 2)-like2 (NRF2) nuclear translocation along with NRF2-dependent upregulation of antioxidative enzymes, and modulation of mammalian target of rapamycin (mTOR) signalling pathway were identified as mechanisms leading to neuroprotection and the survival of dopaminergic cells. The neuroprotective effect of IGF-II against MPP + -neurotoxicity on dopaminergic neurons depends on the specific IGF-II receptor (IGF-IIr). In the mouse model, IGF-II prevents behavioural dysfunction and dopaminergic nigrostriatal pathway degeneration and mitigates neuroinflammation induced by MPP+. Our work demonstrates that hampering oxidative stress and normalising mitochondrial function through the interaction of IGF-II with its specific IGF-IIr are neuroprotective in both neuronal and mouse models. Thus, the modulation of the IGF-II/IGF-IIr signalling pathway may be a useful therapeutic approach for the prevention and treatment of PD.


Asunto(s)
Enfermedad de Parkinson , 1-Metil-4-fenilpiridinio/toxicidad , Animales , Neuronas Dopaminérgicas , Factor II del Crecimiento Similar a la Insulina , Ratones , Estrés Oxidativo , Enfermedad de Parkinson/tratamiento farmacológico
7.
Brain Sci ; 11(8)2021 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-34439724

RESUMEN

Stress seems to contribute to the neuropathology of Parkinson's disease (PD), possibly by dysregulation of the hypothalamic-pituitary-adrenal axis. Oxidative distress and mitochondrial dysfunction are key factors involved in the pathophysiology of PD and neuronal glucocorticoid-induced toxicity. Animal PD models have been generated to study the effects of hormonal stress, but no in vitro model has yet been developed. Our aim was to examine the impact of corticosterone (CORT) administration on a dopaminergic neuronal cell model of PD induced by the neurotoxin MPP+, as a new combined PD model based on the marker of endocrine response to stress, CORT, and oxidative-mitochondrial damage. We determined the impact of CORT, MPP+ and their co-incubation on reactive oxygen species production (O2-•), oxidative stress cellular markers (advanced-oxidation protein products and total antioxidant status), mitochondrial function (mitochondrial membrane potential and mitochondrial oxygen consumption rate) and neurodegeneration (Fluoro-Jade staining). Accordingly, the administration of MPP+ or CORT individually led to cell damage compared to controls (p < 0.05), as determined by several methods, whereas their co-incubation produced strong cell damage (p < 0.05). The combined model described here could be appropriate for investigating neuropathological hallmarks and for evaluating potential new therapeutic tools for PD patients suffering mild to moderate emotional stress.

8.
Sci Data ; 8(1): 193, 2021 07 28.
Artículo en Inglés | MEDLINE | ID: mdl-34321488

RESUMEN

This paper introduces the SEA database (acronym for Spanish Electoral Archive). SEA brings together the most complete public repository available to date on Spanish election outcomes. SEA holds all the results recorded from the electoral processes of General (1979-2019), Regional (1989-2021), Local (1979-2019) and European Parliamentary (1987-2019) elections held in Spain since the restoration of democracy in the late 70 s, in addition to other data sets with electoral content. The data are offered for free and is presented in a homogeneous and friendly format. Most of the databases are available for download with data from various electoral levels, including from the ballot box level. This paper details how the information is organized, what the main variables are on offer for each election, which processes were applied to the data for their homogenization, and discusses future areas of work. This data has many applications, for example, as inputs in election prediction models and in ecological inference algorithms, to study determinants of turnout or voting, or for defining marketing strategies.

9.
Stat Med ; 40(4): 865-884, 2021 02 20.
Artículo en Inglés | MEDLINE | ID: mdl-33174250

RESUMEN

The correct identification of change-points during ongoing outbreak investigations of infectious diseases is a matter of paramount importance in epidemiology, with major implications for the management of health care resources, public health and, as the COVID-19 pandemic has shown, social live. Onsets, peaks, and inflexion points are some of them. An onset is the moment when the epidemic starts. A "peak" indicates a moment at which the incorporated values, both before and after, are lower: a maximum. The inflexion points identify moments in which the rate of growth of the incorporation of new cases changes intensity. In this study, after interpreting the concept of elasticity of a random variable in an innovative way, we propose using it as a new simpler tool for anticipating epidemic remission change-points. In particular, we propose that the "remission point of change" will occur just at the instant when the speed in the accumulation of new cases is lower than the average speed of accumulation of cases up to that moment. This gives stability and robustness to the estimation in the event of possible remission variations. This descriptive measure, which is very easy to calculate and interpret, is revealed as informative and adequate, has the advantage of being distribution-free and can be estimated in real time, while the data is being collected. We use the 2014-2016 Western Africa Ebola virus epidemic to demonstrate this new approach. A couple of examples analyzing COVID-19 data are also included.


Asunto(s)
Epidemias , Métodos Epidemiológicos , COVID-19/epidemiología , Simulación por Computador , Humanos , Pandemias , Modelos de Riesgos Proporcionales , Inducción de Remisión , Tiempo
10.
Antioxidants (Basel) ; 11(1)2021 Dec 24.
Artículo en Inglés | MEDLINE | ID: mdl-35052545

RESUMEN

Stress seems to contribute to Parkinson's disease (PD) neuropathology, probably by dysregulation of the hypothalamic-pituitary-adrenal axis. Key factors in this pathophysiology are oxidative stress and mitochondrial dysfunction and neuronal glucocorticoid-induced toxicity. The insulin-like growth factor II (IGF-II), a pleiotropic hormone, has shown antioxidant and neuroprotective effects in some neurodegenerative disorders. Our aim was to examine the protective effect of IGF-II on a dopaminergic cellular combined model of PD and mild to moderate stress measuring oxidative stress parameters, mitochondrial and neuronal markers, and signalling pathways. IGF-II counteracts the mitochondrial-oxidative damage produced by the toxic synergistic effect of corticosterone and 1-methyl-4-phenylpyridinium, protecting dopaminergic neurons from death and neurodegeneration. IGF-II promotes PKC activation and nuclear factor (erythroid-derived 2)-like 2 antioxidant response in a glucocorticoid receptor-dependent pathway, preventing oxidative cell damage and maintaining mitochondrial function. Thus, IGF-II is a potential therapeutic tool for treatment and prevention of disease progression in PD patients suffering mild to moderate emotional stress.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA